Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Search results are limited to:
Abstract Book of the 7th European Myeloma Network Meeting, Prague, 16-18 April 2026
Vol. 111 No. s2
Advanced filters
Search the full archive

B04 | BLOOD-BASED RISK STRATIFICATION OF MYELOMA PATIENTS USING CIRCULATING TUMOR CELLS: RESULTS FROM THE EUROPEAN CTC CONSORTIUM (364 Online Views)

L. Bertamini1, D. Zihala2, I.V. Kostopoulos3, M. D’Agostino4, E. Martín-Sánchez5, J.J. Garcés Latre5, D. Hofste Op Bruinink1, N. Puig6, S. Zweegman7, G. Bertuglia4, P. Malandrakis8, T. Sevcikova2, T. Cupedo1, N.W.C.J. Van De Donk7, M.T. Cedena9, P. Musto10, I. Ntanasis-Stathopoulos8, O. Venglar2, M. Van Duin1, J.J. Lahuerta9, D. Rota Scalabrini11, O. Tsitsilonis3, T. Popkova2, J. Blade12, E. Zamagni13, M. Gavriatopoulou8, L. Muronova2, B. Van Der Holt1|14, P.. Moreau15, M.V. Mateos6, M. Galli16, E. Katodritou17, M. Stork18, A. Belotti19, P. Rousakis3, M. Borsky18, J. Corre20, M. Boccadoro21, M. Dimopoulos8, R. Hajek2, J. San Miguel5, P. Sonneveld1, F. Gay4, E. Terpos8, A. Broijl1, B. Paiva3, T. Jelinek2

1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
2 Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Czech Republic
3 Department of Biology, School of Science, National and Kapodistrian University of Athens, Greece
4 Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, Italy
5 Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain
6 Hospital Universitario,Salamanca, Spain
7 Department of Hematology, Amsterdam University Medical Center and Vrije Universiteit Amsterdam, the Netherlands
8 Department of Clinical Therapeutics School of Medicine, National and Kapodistrian University of Athens, Greece
9 Hospital Universitario 12 De Octubre, Madrid, Spain
10 Department of Precision and Regenerative Medicine and Ionian Area,"Aldo Moro" University School of Medicine, and Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy
11 Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Torino, Italy
12 Hospital Clínic de Barcelona, Spain
13 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Italy
14 HOVON Foundation, Rotterdam, the Netherlands
15 Hematology Department, University Hospital Hôtel-Dieu, Nantes, France
16 Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale-Papa Giovanni XXIII, Bergamo, Italy
17 Department of Hematology, Theageneio Cancer Hospital, Thessaloniki, Greece
18 Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Czech Republic
19 Department of Hematology, ASST Spedali Civili di Brescia, Italy
20 Unité de Génomique du Myélome, University Hospital, IUCT-Oncopole, CRCT, Toulouse, France
21 European Myeloma Network, EMN
Circulating Tumor Cells Multiple Myeloma Plasma Cell Egression.

P01 | CIRCULATING TUMOR CELLS IMPROVE RISK STRATIFICATION ACCORDING TO THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM AND THE IMS-IMWG CONSENSUS GENOMIC STAGING IN NDMM PATIENTS. AN ANALYSIS FROM THE EUROPEAN CTC CONSORTIUM (326 Online Views)

M. D’Agostino1, E. Martín-Sánchez2, D. Žihala3|4, I. Kostopoulos5, J.J. Garcés6, N. Puig7, G. Bertuglia1, T. Ševčíková3, T. Cupedo8, M. Van Duin8, J. Keats9, E. Zamagni10|11, P. Moreau12, S. Zweegman13, B. Van Der Holt8|14, D. Hofste Op Bruinink8, E. Dama15, J. Corre16, M. Boccadoro15, M.A. Dimopoulos17|18, R. Hájek3|4, B. Paiva2, P. Sonneveld8|19, A. Broijl8, E. Terpos17, T. Jelínek3|4, J. San-Miguel2, F. Gay1, L. Bertamini8

1 Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, Italy
2 Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain
3 Department of Hematooncology, University Hospital Ostrava, Czech Republic
4 Department of Hematooncology, Faculty of Medicine, University of Ostrava, Czech Republic
5 School of Science, National and Kapodistrian University of Athens, Greece
6 Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, USA
7 Hospital Universitario Salamanca, Spain
8 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
9 Clinical Genomics and Therapeutics Division, Translational Genomics Research Institute, Phoenix, USA
10 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Italy
11 Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Italy
12 Hematology Department, University Hospital Hôtel-Dieu, Nantes, France
13 Department of Hematology, Amsterdam University Medical Center and Vrije Universiteit, The Netherlands
14 HOVON Foundation, Rotterdam, The Netherlands
15 European Myeloma Network, Italy
16 Unité de Génomique du Myélome, University Hospital, IUCT-Oncopole, CRCT, Toulouse, France
17 Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece
18 Department of Medicine, Korea University, Seoul, Korea
19 European Myeloma Network, The Netherlands
Circulating Tumor Plasma Cells NDMM European CTC Consortium.

P15 | RANDOMIZED COMPARISON OF ISATUXIMAB–RD INDUCTION FOLLOWED BY ISA R MAINTENANCE VS. RD INDUCTION FOLLOWED BY R MAINTENANCE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (AGMT MM04 TRIAL) (361 Online Views)

H. Ludwig1, T. Melchardt2, E. Terpos3, J. Bila4, M. Schreder5, S. Bernhard1, K. Podar6, E. Katodritou7, T. Sliwa8, P. Djurdjevic9, S. Delimpasi10, M. Leisch2, M. Mitrovic4, M. Gavriatopoulou3, I. Ntanasis-Stathopoulos3, E.M. Autzinger11, A. Zabernigg12, M. Fillitz13, E. Wöll14, P. Pichler15, I.M. Sáenz De Tejada16|17|18, B. Paiva16|17|18, R. Greil19|20|21|22|23|24|25

1 Wilhelminen Cancer Research Institute, First Department of Medicine, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria
2 Department of Internal Medicine III With Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Paracelsus Medical University, Vienna, Austria
3 Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece
4 Clinic of the Hematology, University Clinical Center of Serbia, Belgrade, Serbia
5 First Department of Medicine, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria
6 Division of Internal Medicine 2, University Hospital Krems, Krems an der Donau, Austria
7 Department of Haematology, Theagenion Anticancer General Hospital, Thessaloniki, Greece
8 Department of Hemato-Oncology, LKH Hochsteiermark-Leoben, Austria
9 Clinic of Hematology, University Clinical Center of Kragujevac, Serbia
10 Hematology, Evangelismos Hospital, Athens, Greece
11 First Department of Medicine, Hematology and Oncology, Hospital Barmherzige Schwestern, Vienna, Austria
12 Department of Internal Medicine, County Hospital Kufstein, Austria
13 Department of Internal Medicine, Hanusch Krankenhaus, Vienna, Austria
14 Department of Internal Medicine, St. Vinzenz Hospital, Zams, Austria
15 Department of Internal Medicine, University Hospital of St. Pölten, Austria
16 Clínica Universidad de Navarra, Centro de Investigaciones Biomédicas Aplicadas
17 (CIMA), Instituto de Investigación Sanitaria de Navarra
18 (IdiSNA), Pamplona, Spain
19 Austrian Group for Medical Tumor Therapy
20 (AGMT)GmbH, Salzburg, Austria
21 Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research
22 (SCRI-LIMCR), Austria
23 Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials
24 (SCRI-CCCIT)GmbH, Austria
25 Cancer Cluster Salzburg, Austria
NDMM Isa-Rd Multiple Myeloma
1 - 3 of 3 items
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online